| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |